跳至主要内容
临床试验/NCT02782455
NCT02782455已完成4 期

Calcium Dobesilate vs Flavonoids for the Treatment of Early Hemorrhoidal Disease a Randomised Triple Blind Controlled Trial

Services Hospital, Lahore1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2016年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
100
试验地点
1
主要终点
Frequency of occurrence of rectal bleeding after usage of drug

研究概览

简要总结

Haemorrhoids are vascular cushions in the anal canal that help in the control of stool. When inflamed they become pathological and may present with protrusion and bleeding. A randomized, triple blind , controlled study will be conducted to compare the efficacy of calcium dobesilate against flavanoids in the management of early haemorrhoidal disease.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
13 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Grade I and Grade II hemorrhoids

排除标准

  • colorectal/ anorectal Malignancy
  • self medication
  • local Quack Hakeem medication
  • pregnancy

研究组 & 干预措施

CDobi

Experimental

Calcium dobesylate is given in this group

干预措施: CDobi (Drug)

Flavono

Active Comparator

Flavonoids are given in this group

干预措施: Flavonoids (Drug)

结局指标

主要结局

Frequency of occurrence of rectal bleeding after usage of drug

时间窗: 1 weeks

After the patients will be given the two drugs they will be followed for the frequency of occurrence of rectal bleeding till two weeks

次要结局

  • regression of hemorrhoids(1 weeks)

研究者

发起方
Services Hospital, Lahore
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Dr. SamiUllah

Postgraduate trainee

Services Hospital, Lahore

研究点 (1)

Loading locations...

相似试验